Thomas, Reuben
No ORCID on file
· 17 papers in corpus
2022
Additional file 1: Table S1. Samples used in the study. Endo: endometriosis; PE: proliferative; SE: secretory: MSE: mid secretory, LSE: late secretory; N/A: not applicable.
2022
Additional file 2: Table S2. CyTOF panels used in the study. Left: broad panel, right: focused panel.
2022
Additional file 3: Fig. S1. Manual gating strategy for the focused panel. The figure shows an example of the dot plots obtained using FlowJo in endometrial cells.
2022
Additional file 3: Fig. S1. Manual gating strategy for the focused panel. The figure shows an example of the dot plots obtained using FlowJo in endometrial cells.
2022
Additional file 4: Fig. S2. Endometrial sampling methods. A) The figure shows UMAPs of the two methods used for endometrial tissue collection, biopsy (red) and hysterectomy (blue). The left panel shows a UMAP with the overlap between the tw…
2022
Additional file 4: Fig. S2. Endometrial sampling methods. A) The figure shows UMAPs of the two methods used for endometrial tissue collection, biopsy (red) and hysterectomy (blue). The left panel shows a UMAP with the overlap between the tw…
2022
Additional file 5: Fig. S3. Batch effects derived from different runs. The figure shows UMAPs representing the distribution of the cells from the runs in the CyTOF instrument for both endometrium (top panel) and PBMCs (bottom panel). The fi…
2022
Additional file 5: Fig. S3. Batch effects derived from different runs. The figure shows UMAPs representing the distribution of the cells from the runs in the CyTOF instrument for both endometrium (top panel) and PBMCs (bottom panel). The fi…
2022
Additional file 6: Fig. S4. Proportion of endometrial immune populations identified by using the broad panel. The figure shows the proportion of each population in the ring graphs and the percentage of each population is also shown in each …
2022
Additional file 6: Fig. S4. Proportion of endometrial immune populations identified by using the broad panel. The figure shows the proportion of each population in the ring graphs and the percentage of each population is also shown in each …
2022
Additional file 7: Fig. S5. Fluctuation of all endometrial immune populations identified in the broad panel. A) Differences in abundance of populations throughout the menstrual cycle in control samples. B) Differences in abundance of popula…
2022
Additional file 7: Fig. S5. Fluctuation of all endometrial immune populations identified in the broad panel. A) Differences in abundance of populations throughout the menstrual cycle in control samples. B) Differences in abundance of popula…
2022
Additional file 8: Fig. S6. Fluctuation of all endometrial immune populations identified in the focused panel. A) Differences in abundance of populations throughout the menstrual cycle in control samples. B) Differences in abundance of popu…
2022
Additional file 8: Fig. S6. Fluctuation of all endometrial immune populations identified in the focused panel. A) Differences in abundance of populations throughout the menstrual cycle in control samples. B) Differences in abundance of popu…
2022
Additional file 9: Table S3. Expression of the significant markers between endometriosis and controls in all cell types in endometriosis versus controls from the focused panel. Significant values are highlighted in grey. Endo: endometriosis…
observational
2022
Abstract Background Endometriosis is a chronic, estrogen-dependent disorder where inflammation contributes to disease-associated symptoms of pelvic pain and infertility. Immune dysfunction includes insufficient immune lesion clearance, a pr…
observational
2022
Abstract Background Endometriosis is a chronic, estrogen-dependent disorder where inflammation contributes to disease-associated symptoms of pelvic pain and infertility. Immune dysfunction includes insufficient immune lesion clearance, a pr…